RICE-ibrutinib in Relapsed DLBCL

NCT02955628 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Diffuse Large B-Cell Lymphoma Recurrent

Interventions

DRUG: Ibrutinib-RICE

Sponsor

Singapore General Hospital

Collaborators

[object Object]